Nest Genomics Closes $8.5 Million Seed Financing to Bring Genomics into Mainstream Patient Care
Retrieved on:
Tuesday, January 10, 2023
Technology, Finance, Consulting, Genetics, Other Technology, Health Technology, Professional Services, Software, Health, Disease, Genetic testing, Adoption of electronic medical records in U.S. hospitals, Public health, Y Combinator, American College, General partnership, Nucleic acid sequence, Polygene, Pediatrics, Scores, Genomics, American College of Medical Genetics and Genomics, Pharmacogenomics, Health, Cancer, Electronic health record, Genetic counseling, EMR, Patient, Medicine, Medical genetics, Pharmaceutical industry, Nest, Invitae
Nest is an end-to-end solution designed to help health systems, clinics, pharmaceutical companies, and payors launch and scale longitudinal genomic programs.
Key Points:
- Nest is an end-to-end solution designed to help health systems, clinics, pharmaceutical companies, and payors launch and scale longitudinal genomic programs.
- The Electronic Medical Records (EMR)-integrated platform allows for the seamless incorporation of genomics into clinical practice within existing workflows, including clinical decision support to help providers create patient care plans based on the latest clinical guidelines and patient information.
- The solution also includes patient engagement tools that empower patients to understand and manage their genetic information over time.
- To realize this potential, we must address the major challenges of incorporating genetic information into provider workflows and patient care,” said Moran Snir, Nest Genomics Co-Founder and CEO.